122 related articles for article (PubMed ID: 6582521)
21. Malignant hematopoietic cell lines: in vitro models for the study of erythroleukemia.
Drexler HG; Matsuo Y; MacLeod RA
Leuk Res; 2004 Dec; 28(12):1243-51. PubMed ID: 15475063
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of erythroid differentiation of mouse erythroleukemia cells by a macrophage product(s).
Sassa S; Wolpe S; Cerami A
Blood Cells; 1987; 13(1-2):161-9. PubMed ID: 3478107
[TBL] [Abstract][Full Text] [Related]
23. Dissociation of hemoglobin accumulation and commitment during murine erythroleukemia cell differentiation by treatment with imidazole.
Gusella JF; Tsiftsoglou AS; Volloch V; Weil SC; Neumann J; Housman DE
J Cell Physiol; 1982 Oct; 113(1):179-85. PubMed ID: 6957412
[TBL] [Abstract][Full Text] [Related]
24. Tumor promoter-induced adhesion of the DS19 clone of murine erythroleukemia cells.
Yamasaki H; Weinstein IB; Fibach E; Rifkind RA; Marks PA
Cancer Res; 1979 Jun; 39(6 Pt 1):1989-94. PubMed ID: 286635
[No Abstract] [Full Text] [Related]
25. Differentiation in chronic myelogenous leukemia cell K562 by spongean sesterterpene.
Aoki S; Higuchi K; Isozumi N; Matsui K; Miyamoto Y; Itoh N; Tanaka K; Kobayashi M
Biochem Biophys Res Commun; 2001 Mar; 282(2):426-31. PubMed ID: 11401476
[TBL] [Abstract][Full Text] [Related]
26. Spi-1/PU.1 proto-oncogene induces opposite effects on monocytic and erythroid differentiation of K562 cells.
Delgado MD; Gutiérrez P; Richard C; Cuadrado MA; Moreau-Gachelin F; León J
Biochem Biophys Res Commun; 1998 Nov; 252(2):383-91. PubMed ID: 9826539
[TBL] [Abstract][Full Text] [Related]
27. Cisplatin-induced erythroid differentiation in K562 cells: modulation of transferrin receptor.
Parodi MT; Tonini GP; Bologna R; Franchini E; Cornaglia-Ferraris P
Boll Ist Sieroter Milan; 1988; 67(2):142-8. PubMed ID: 3228498
[TBL] [Abstract][Full Text] [Related]
28. Hemopoietic precursor cells in erythroleukemia.
Suda T; Miura Y; Ozawa K; Mizoguchi H; Takaku F
Stem Cells (1981); 1982; 1(4-5):224-32. PubMed ID: 6959295
[TBL] [Abstract][Full Text] [Related]
29. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
Chen YL; Wu RT
Cancer Res; 1994 Apr; 54(8):2192-8. PubMed ID: 7513611
[TBL] [Abstract][Full Text] [Related]
30. Protease induction of hemoglobin synthesis but not terminal cell division in K562 cells.
Scher W; Hellinger N; Waxman S
Exp Hematol; 1985 Jan; 13(1):36-43. PubMed ID: 3882441
[TBL] [Abstract][Full Text] [Related]
31. Tumor promoters inhibit spontaneous differentiation of Friend erythroleukemia cells in culture.
Rovera G; O'Brien TG; Diamond L
Proc Natl Acad Sci U S A; 1977 Jul; 74(7):2894-8. PubMed ID: 268640
[TBL] [Abstract][Full Text] [Related]
32. Basic fibroblast growth factor modulates the expression of glycophorin A and c-kit and inhibits erythroid differentiation in K562 cells.
Burger PE; Lukey PT; Coetzee S; Wilson EL
J Cell Physiol; 2002 Jan; 190(1):83-91. PubMed ID: 11807814
[TBL] [Abstract][Full Text] [Related]
33. Fast apoptosis and erythroid differentiation induced by imatinib mesylate in JURL-MK1 cells.
Kuzelová K; Grebenová D; Marinov I; Hrkal Z
J Cell Biochem; 2005 May; 95(2):268-80. PubMed ID: 15770664
[TBL] [Abstract][Full Text] [Related]
34. [Inducers of cell differentiation in acute myeloid leukemias].
Sánchez Fayos J
Sangre (Barc); 1981; 26(5-A):619-25. PubMed ID: 6976644
[No Abstract] [Full Text] [Related]
35. Regulation of c-Myc and Max in megakaryocytic and monocytic-macrophagic differentiation of K562 cells induced by protein kinase C modifiers: c-Myc is down-regulated but does not inhibit differentiation.
Lerga A; Crespo P; Berciano M; Delgado MD; Cañelles M; Calés C; Richard C; Ceballos E; Gutierrez P; Ajenjo N; Gutkind S; León J
Cell Growth Differ; 1999 Sep; 10(9):639-54. PubMed ID: 10511314
[TBL] [Abstract][Full Text] [Related]
36. RNA polymerase II inhibitor, 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) causes erythroleukemic differentiation and transcriptional activation of erythroid genes.
Hensold JO; Barth D; Stratton CA
J Cell Physiol; 1996 Jul; 168(1):105-13. PubMed ID: 8647904
[TBL] [Abstract][Full Text] [Related]
37. Nitric oxide levels during erythroid differentiation in K562 cell line.
Küçükkaya B; Oztürk G; Yalçintepe L
Indian J Biochem Biophys; 2006 Aug; 43(4):251-3. PubMed ID: 17133771
[TBL] [Abstract][Full Text] [Related]
38. The close relationship between DNA replication and the selection of differentiation lineages of human erythroleukemia cell lines K562, HEL, and TF1 into either erythroid or megakaryocytic lineages.
Murate T; Saga S; Hotta T; Asano H; Ito T; Kato K; Tsushita K; Kinoshita T; Ichikawa A; Yoshida S
Exp Cell Res; 1993 Sep; 208(1):35-43. PubMed ID: 8359227
[TBL] [Abstract][Full Text] [Related]
39. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ
Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953
[TBL] [Abstract][Full Text] [Related]
40. Evidence for distinction of the differentiation-inducing activities and cytostatic properties of 9-(2-phosphonylmethoxyethyl)adenine and a variety of differentiation-inducing agents in human erythroleukemia K562 cells.
Hatse S; De Clercq E; Balzarini J
Mol Pharmacol; 1996 Nov; 50(5):1231-42. PubMed ID: 8913355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
